Gannett - GCI Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Gannett in the last twelve months. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" GCI shares.
View GCI analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued 12 month price targets for Gannett's shares. Their GCI share price forecasts range from $2.10 to $2.10. On average, they predict the company's share price to reach $2.10 in the next year. This suggests that the stock has a possible downside of 19.5%.
View analysts price targets for GCI or view top-rated stocks among Wall Street analysts.

Gannett's stock was trading at $5.33 at the beginning of the year. Since then, GCI stock has decreased by 51.0% and is now trading at $2.61.
View the best growth stocks for 2022 here.

Gannett saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 16,460,000 shares, an increase of 9.7% from the October 31st total of 15,000,000 shares. Based on an average daily volume of 1,330,000 shares, the days-to-cover ratio is presently 12.4 days. Approximately 12.0% of the shares of the stock are sold short.
View Gannett's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our GCI earnings forecast.

Gannett Co., Inc. (NYSE:GCI) posted its earnings results on Thursday, November, 3rd. The company reported $0.35 EPS for the quarter. The firm earned $717.90 million during the quarter. Gannett had a positive trailing twelve-month return on equity of 15.14% and a negative net margin of 4.38%.

Gannett updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.95 billion-$3.00 billion, compared to the consensus revenue estimate of $3.00 billion.

Based on aggregate information from My MarketBeat watchlists, some companies that other Gannett investors own include Washington Prime Group (WPG), CBL & Associates Properties (CBL), EnLink Midstream (ENLC), Golar LNG Partners (GMLP), Pennsylvania Real Estate Investment Trust (PEI), Matinas BioPharma (MTNB), Gran Tierra Energy (GTE), CNBX Pharmaceuticals (CNBX), New Residential Investment (NRZ) and ADMA Biologics (ADMA).

Gannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "GCI."

Gannett's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.51%), Vanguard Group Inc. (7.34%), State Street Corp (4.21%), Dimensional Fund Advisors LP (2.66%), Assenagon Asset Management S.A. (0.99%) and Bank of New York Mellon Corp (0.89%). Insiders that own company stock include John Jeffry Louis, Laurence Tarica, Michael Reed and Theodore Peter Janulis.
View institutional ownership trends.

Shares of GCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GCI stock can currently be purchased for approximately $2.61.

Gannett (NYSE:GCI) has a market capitalization of $381.30 million and generates $3.21 billion in revenue each year. The company earns $-134,960,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis.

The company employs 13,800 workers across the globe.

Gannett's mailing address is 7950 Jones Branch Drive, McLean VA, 22107. The official website for the company is www.newmediainv.com. The company can be reached via phone at 703-854-6000 or via email at investors@gannett.com.